help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labrie, C.
Right arrow Articles by Labrie, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labrie, C.
Right arrow Articles by Labrie, F.

Endocrinology, Vol 123, 1412-1417, Copyright © 1988 by Endocrine Society

ARTICLES

Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate

C Labrie, A Belanger and F Labrie
Medical Research Council Group in Molecular Endocrinology, Laval University Medical Center, Quebec, Canada.

In order to assess the androgenic potency of physiological plasma concentrations of the adrenal steroids dehydroepiandrosterone (DHEA) and androstenedione (delta 4-dione) in the rat prostate, these two steroids were released from Silastic tubings of appropriate length and size in castrated male rats. Implants of DHEA led to plasma levels of DHEA and 5-androsten-3 beta,17 beta-diol covering the range of concentrations found in adult men while no significant change was observed in plasma levels of delta 4-dione, testosterone and dihydrotestosterone (DHT). delta 4-Dione implants, on the other hand, led to a parallel increase in plasma delta 4-dione and testosterone levels at all doses used while plasma DHT only increased at supraphysiological doses of delta 4-dione. At plasma concentrations comparable to those found in adult men; delta 4-dione (0.8 ng/ml) and DHEA (3.4 ng/ml) stimulated prostate weight 3.7- and 2.1-fold, respectively. In the same groups, prostatic DHT levels were elevated at 4.48 +/- 0.05 and 2.70 +/- 0.73 ng/g tissue, respectively. A close parallelism was observed between prostatic DHT levels and prostatic weight in all groups. The present data show that in the rat, a species having no significant secretion of adrenal androgens, plasma concentrations of DHEA and delta 4-dione maintained within the range of those found in adult men are efficiently converted into DHT and act as potent androgenic stimuli in prostatic tissue. The castrated rat bearing Silastic implants releasing constant and predetermined amounts of adrenal steroids offers a good model to study the recently identified role of adrenal steroids in peripheral tissues.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. R. Plymate, K. Haugk, I. Coleman, L. Woodke, R. Vessella, P. Nelson, R. B. Montgomery, D. L. Ludwig, and J. D. Wu
An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer
Clin. Cancer Res., November 1, 2007; 13(21): 6429 - 6439.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Cantin, F. Faucher, J.-F. Couture, K. P. de Jesus-Tran, P. Legrand, L. C. Ciobanu, Y. Frechette, R. Labrecque, S. M. Singh, F. Labrie, et al.
Structural Characterization of the Human Androgen Receptor Ligand-binding Domain Complexed with EM5744, a Rationally Designed Steroidal Ligand Bearing a Bulky Chain Directed toward Helix 12
J. Biol. Chem., October 19, 2007; 282(42): 30910 - 30919.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M. Panjari and S. R. Davis
DHEA therapy for women: effect on sexual function and wellbeing
Hum. Reprod. Update, May 1, 2007; 13(3): 239 - 248.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
F Labrie
Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A S Chagin, D Chrysis, M Takigawa, E M Ritzen, and L Savendahl
Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis
J. Endocrinol., February 1, 2006; 188(2): 193 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
V. Luu-The, P. Tremblay, and F. Labrie
Characterization of Type 12 17{beta}-Hydroxysteroid Dehydrogenase, an Isoform of Type 3 17{beta}-Hydroxysteroid Dehydrogenase Responsible for Estradiol Formation in Women
Mol. Endocrinol., February 1, 2006; 20(2): 437 - 443.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie
Is dehydroepiandrosterone a hormone?
J. Endocrinol., November 1, 2005; 187(2): 169 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. Labrie, A. Belanger, V. Luu-The, C. Labrie, J. Simard, L. Cusan, J. Gomez, and B. Candas
Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer
Endocr. Rev., May 1, 2005; 26(3): 361 - 379.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F. Labrie, V. Luu-The, E. Calvo, C. Martel, J. Cloutier, S. Gauthier, P. Belleau, J. Morissette, M.-H. Levesque, and C. Labrie
Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid
J. Endocrinol., February 1, 2005; 184(2): 427 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
G. Pelletier, V. Luu-The, S. Li, J. Ouellet, and F. Labrie
Cellular Localization of mRNA Expression of Enzymes Involved in the Formation and Inactivation of Hormonal Steroids in the Mouse Prostate
J. Histochem. Cytochem., October 1, 2004; 52(10): 1351 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Martin, M. Ross, K. E. Chapman, R. Andrew, P. Bollina, J. R. Seckl, and F. K. Habib
CYP7B Generates a Selective Estrogen Receptor {beta} Agonist in Human Prostate
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2928 - 2935.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. C. J. van der Eerden, M. Karperien, and J. M. Wit
Systemic and Local Regulation of the Growth Plate
Endocr. Rev., December 1, 2003; 24(6): 782 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier
Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
Endocr. Rev., April 1, 2003; 24(2): 152 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Rouleau, A. Dagnault, D. Simard, B. Lavallee, A. Belanger, A. Blouin, and J. G. Kingma Jr.
Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1407 - H1412.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. El-Alfy, V. Luu-The, X.-F. Huang, L. Berger, F. Labrie, and G. Pelletier
Localization of Type 5 17{beta}-Hydroxysteroid Dehydrogenase, 3{beta}-Hydroxysteroid Dehydrogenase, and Androgen Receptor in the Human Prostate by in Situ Hybridization and Immunocytochemistry
Endocrinology, March 1, 1999; 140(3): 1481 - 1491.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
A. Sourla, C. Martel, C. Labrie, and F. Labrie
Almost Exclusive Androgenic Action of Dehydroepiandrosterone in the Rat Mammary Gland
Endocrinology, February 1, 1998; 139(2): 753 - 764.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Labrie, P. Diamond, L. Cusan, J.-L. Gomez, A. Belanger, and B. Candas
Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal Women
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3498 - 3505.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Luo, A. Sourla, C. Labrie, A. Belanger, and F. Labrie
Combined Effects of Dehydroepiandrosterone and EM-800 on Bone Mass, Serum Lipids, and the Development of Dimethylbenz(A)Anthracene-Induced Mammary Carcinoma in the Rat
Endocrinology, October 1, 1997; 138(10): 4435 - 4444.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Labrie, A. Belanger, L. Cusan, J.-L. Gomez, and B. Candas
Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites During Aging
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2396 - 2402.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Labrie, A. Belanger, L. Cusan, and B. Candas
Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2403 - 2409.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Luo, C. Labrie, A. Belanger, and F. Labrie
Effect of Dehydroepiandrosterone on Bone Mass, Serum Lipids, and Dimethylbenz(a)anthracene-Induced Mammary Carcinoma in the Rat
Endocrinology, August 1, 1997; 138(8): 3387 - 3394.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Guillemette, E. Levesque, M. Beaulieu, D. Turgeon, D. W. Hum, and A. Belanger
Differential Regulation of Two Uridine Diphospho-Glucuronosyltransferases, UGT2B15 and UGT2B17, in Human Prostate LNCaP Cells
Endocrinology, July 1, 1997; 138(7): 2998 - 3005.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society